Enhanced snoMEN Vectors Facilitate Institution of GFP-HIF-1α Protein Substitute Human Cell Traces.
The snoMEN (snoRNA Modulator of gene ExpressioN) vector expertise was developed from a human field C/D snoRNA, HBII-180C, which accommodates an inside sequence that may be manipulated to make it complementary to RNA targets, permitting knock-down of focused genes. Right here we’ve got screened further human nucleolar snoRNAs and assessed their software for gene particular knock-downs to enhance the effectivity of snoMEN vectors.
We establish and characterise a brand new snoMEN vector, termed 47snoMEN, that’s derived from field C/D snoRNA U47, demonstrating its use for knock-down of each endogenous mobile proteins and G/YFP-fusion proteins.
Utilizing multiplex 47snoMEM vectors that co-express a number of 47snoMEN in a single transcript, every of which may goal totally different websites in the identical mRNA, we doc >3-fold improve in knock-down effectivity when put next with the unique HBII-180C primarily based snoMEN.
The multiplex 47snoMEM vector allowed the development of human protein alternative cell traces with improved effectivity, together with the institution of novel GFP-HIF-1α alternative cells.
Quantitative mass spectrometry evaluation confirmed the improved effectivity and specificity of protein alternative utilizing the 47snoMEN-PR vectors. The 47snoMEN vectors develop the potential purposes for snoMEN expertise in gene expression research, goal validation and gene remedy
gfpvector
NACC1 Antibody |
|||
| CSB-PA283286- | Cusabio | EUR 402 | |
|
Description: A polyclonal antibody against NACC1. Recognizes NACC1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
|||
NACC1 Antibody |
|||
| CSB-PA283286-100ul | Cusabio | 100ul | EUR 379.2 |
|
Description: A polyclonal antibody against NACC1. Recognizes NACC1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
|||
NACC1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
| LV693127 | ABM | 1.0 ug DNA | EUR 818.4 |
NACC1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV693131 | ABM | 1.0 ug DNA | EUR 818.4 |
NACC1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV693132 | ABM | 1.0 ug DNA | EUR 818.4 |
Human NACC1 shRNA Plasmid |
|||
| 20-abx964300 | Abbexa |
|
|
NACC1 Recombinant Protein (Human) |
|||
| RP077613 | ABM | 100 ug | Ask for price |
Nacc1 ORF Vector (Rat) (pORF) |
|||
| ORF071065 | ABM | 1.0 ug DNA | EUR 607.2 |
Nacc1 ORF Vector (Mouse) (pORF) |
|||
| ORF050990 | ABM | 1.0 ug DNA | EUR 607.2 |
NACC1 Rabbit pAb |
|||
| A11709-100ul | Abclonal | 100 ul | EUR 369.6 |
NACC1 Rabbit pAb |
|||
| A11709-200ul | Abclonal | 200 ul | EUR 550.8 |
NACC1 Rabbit pAb |
|||
| A11709-20ul | Abclonal | 20 ul | EUR 219.6 |
NACC1 Rabbit pAb |
|||
| A11709-50ul | Abclonal | 50 ul | EUR 267.6 |
NACC1 Rabbit pAb |
|||
| A11720-100ul | Abclonal | 100 ul | EUR 369.6 |
NACC1 Rabbit pAb |
|||
| A11720-200ul | Abclonal | 200 ul | EUR 550.8 |
NACC1 Rabbit pAb |
|||
| A11720-20ul | Abclonal | 20 ul | EUR 219.6 |
NACC1 Rabbit pAb |
|||
| A11720-50ul | Abclonal | 50 ul | EUR 267.6 |
NACC1 Blocking Peptide |
|||
| BF0187-BP | Affbiotech | 1mg | EUR 234 |
NACC1 Conjugated Antibody |
|||
| C48470 | SAB | 100ul | EUR 476.4 |
anti-NACC1 (6H2) |
|||
| LF-MA30500 | Abfrontier | 100 ul | EUR 583.2 |
|
Description: Mouse Monoclonal to NACC1 |
|||
Anti-NACC1 antibody |
|||
| STJ113308 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: This gene encodes a member of the BTB/POZ protein family. BTB/POZ proteins are involved in several cellular processes including proliferation, apoptosis and transcription regulation. The encoded protein is a transcriptional repressor that plays a role in stem cell self-renewal and pluripotency maintenance. The encoded protein also suppresses transcription of the candidate tumor suppressor Gadd45GIP1, and expression of this gene may play a role in the progression of multiple types of cancer. A pseudogene of this gene is located on the short arm of chromosome 9. |
|||
Anti-NACC1 antibody |
|||
| STJ113847 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: This gene encodes a member of the BTB/POZ protein family. BTB/POZ proteins are involved in several cellular processes including proliferation, apoptosis and transcription regulation. The encoded protein is a transcriptional repressor that plays a role in stem cell self-renewal and pluripotency maintenance. The encoded protein also suppresses transcription of the candidate tumor suppressor Gadd45GIP1, and expression of this gene may play a role in the progression of multiple types of cancer. A pseudogene of this gene is located on the short arm of chromosome 9. |
|||
NACC1 Protein Vector (Human) (pPB-C-His) |
|||
| PV103486 | ABM | 500 ng | EUR 662.4 |
NACC1 Protein Vector (Human) (pPB-N-His) |
|||
| PV103487 | ABM | 500 ng | EUR 662.4 |
NACC1 Protein Vector (Human) (pPM-C-HA) |
|||
| PV103488 | ABM | 500 ng | EUR 662.4 |
NACC1 Protein Vector (Human) (pPM-C-His) |
|||
| PV103489 | ABM | 500 ng | EUR 662.4 |
Polyclonal NACC1 Antibody (Center) |
|||
| APR04758G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NACC1 (Center). This antibody is tested and proven to work in the following applications: |
|||
Mouse NACC1 shRNA Plasmid |
|||
| 20-abx975804 | Abbexa |
|
|
Rat NACC1 shRNA Plasmid |
|||
| 20-abx987779 | Abbexa |
|
|
NACC1 Recombinant Protein (Rat) |
|||
| RP213191 | ABM | 100 ug | Ask for price |
NACC1 Recombinant Protein (Mouse) |
|||
| RP152966 | ABM | 100 ug | Ask for price |
NACC1 Antibody / NAC1 / BTBD14B |
|||
| RQ6781 | NSJ Bioreagents | 100ug | EUR 419 |
|
Description: Nucleus accumbens-associated protein 1 is a protein that in humans is encoded by the NACC1 gene. This gene encodes a member of the BTB/POZ protein family. BTB/POZ proteins are involved in several cellular processes including proliferation, apoptosis and transcription regulation. The encoded protein is a transcriptional repressor that plays a role in stem cell self-renewal and pluripotency maintenance. The encoded protein also suppresses transcription of the candidate tumor suppressor Gadd45GIP1, and expression of this gene may play a role in the progression of multiple types of cancer. A pseudogene of this gene is located on the short arm of chromosome 9. |
|||
NACC1 Antibody / Nac1 / BTBD14B |
|||
| V9183-100UG | NSJ Bioreagents | 100ug | EUR 499 |
|
Description: The BTB (broad-complex, tramtrack and bric a brac) domain, also known as the POZ (poxvirus and zinc finger) domain, is an N-terminal homodimerization domain that contains multiple copies of kelch repeats and/or C2H2-type zinc fingers. Proteins that contain BTB domains are thought to be involved in transcriptional regulation via control of chromatin structure and function. BTBD14B (BTB/POZ domain-containing protein 14B), also known as NACC1 (nucleus accumbens associated 1), BEND8 or NAC1, is a 527 amino acid protein that localizes to both the nucleus and the cytoplasm and contains one BTB (POZ) domain. Existing as a homo-oligomer that interacts with HDAC3 and HDAC4, BTBD14B functions as a transcriptional repressor that influences the transcriptional activity of CRIF1 and is required for proteasome recruitment to the nucleus and cytoplasm in dendritic spines. BTBD14B is overexpressed in multiple carcinomas, suggesting a role in tumor development and metastasis. |
|||
NACC1 Antibody / Nac1 / BTBD14B |
|||
| V9183-20UG | NSJ Bioreagents | 20ug | EUR 219 |
|
Description: The BTB (broad-complex, tramtrack and bric a brac) domain, also known as the POZ (poxvirus and zinc finger) domain, is an N-terminal homodimerization domain that contains multiple copies of kelch repeats and/or C2H2-type zinc fingers. Proteins that contain BTB domains are thought to be involved in transcriptional regulation via control of chromatin structure and function. BTBD14B (BTB/POZ domain-containing protein 14B), also known as NACC1 (nucleus accumbens associated 1), BEND8 or NAC1, is a 527 amino acid protein that localizes to both the nucleus and the cytoplasm and contains one BTB (POZ) domain. Existing as a homo-oligomer that interacts with HDAC3 and HDAC4, BTBD14B functions as a transcriptional repressor that influences the transcriptional activity of CRIF1 and is required for proteasome recruitment to the nucleus and cytoplasm in dendritic spines. BTBD14B is overexpressed in multiple carcinomas, suggesting a role in tumor development and metastasis. |
|||
NACC1 Antibody / Nac1 / BTBD14B |
|||
| V9183SAF-100UG | NSJ Bioreagents | 100ug | EUR 499 |
|
Description: The BTB (broad-complex, tramtrack and bric a brac) domain, also known as the POZ (poxvirus and zinc finger) domain, is an N-terminal homodimerization domain that contains multiple copies of kelch repeats and/or C2H2-type zinc fingers. Proteins that contain BTB domains are thought to be involved in transcriptional regulation via control of chromatin structure and function. BTBD14B (BTB/POZ domain-containing protein 14B), also known as NACC1 (nucleus accumbens associated 1), BEND8 or NAC1, is a 527 amino acid protein that localizes to both the nucleus and the cytoplasm and contains one BTB (POZ) domain. Existing as a homo-oligomer that interacts with HDAC3 and HDAC4, BTBD14B functions as a transcriptional repressor that influences the transcriptional activity of CRIF1 and is required for proteasome recruitment to the nucleus and cytoplasm in dendritic spines. BTBD14B is overexpressed in multiple carcinomas, suggesting a role in tumor development and metastasis. |
|||
NACC1 sgRNA CRISPR Lentivector set (Human) |
|||
| K1386401 | ABM | 3 x 1.0 ug | EUR 406.8 |
NACC1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
| LV693128 | ABM | 1.0 ug DNA | EUR 818.4 |
NACC1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
| LV693129 | ABM | 1.0 ug DNA | EUR 888 |
NACC1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
| LV693130 | ABM | 1.0 ug DNA | EUR 888 |
NACC1 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV203958 | ABM | 500 ng | EUR 723.6 |
NACC1 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV203959 | ABM | 500 ng | EUR 723.6 |
NACC1 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV203960 | ABM | 500 ng | EUR 723.6 |
NACC1 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV203961 | ABM | 500 ng | EUR 723.6 |
NACC1 Protein Vector (Rat) (pPB-C-His) |
|||
| PV284258 | ABM | 500 ng | EUR 723.6 |
NACC1 Protein Vector (Rat) (pPB-N-His) |
|||
| PV284259 | ABM | 500 ng | EUR 723.6 |
NACC1 Protein Vector (Rat) (pPM-C-HA) |
|||
| PV284260 | ABM | 500 ng | EUR 723.6 |
NACC1 Protein Vector (Rat) (pPM-C-His) |
|||
| PV284261 | ABM | 500 ng | EUR 723.6 |
Polyclonal NACC1 Antibody (C-term) |
|||
| APR04778G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NACC1 (C-term). This antibody is tested and proven to work in the following applications: |
|||
NACC1 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K1386402 | ABM | 1.0 ug DNA | EUR 184.8 |
NACC1 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K1386403 | ABM | 1.0 ug DNA | EUR 184.8 |
NACC1 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K1386404 | ABM | 1.0 ug DNA | EUR 184.8 |
Nucleus Accumbens Associated 1 (NACC1) Antibody |
|||
| 20-abx126214 | Abbexa |
|
|
Nucleus Accumbens Associated 1 (NACC1) Antibody |
|||
| abx011231-100ul | Abbexa | 100 ul | EUR 493.2 |
Nucleus Accumbens Associated 1 (NACC1) Antibody |
|||
| abx330473-100ul | Abbexa | 100 ul | EUR 510 |
Nacc1 sgRNA CRISPR Lentivector set (Rat) |
|||
| K7051401 | ABM | 3 x 1.0 ug | EUR 406.8 |
Nacc1 sgRNA CRISPR Lentivector set (Mouse) |
|||
| K4905601 | ABM | 3 x 1.0 ug | EUR 406.8 |
Human Nucleus accumbens- associated protein 1, NACC1 ELISA KIT |
|||
| ELI-16141h | Lifescience Market | 96 Tests | EUR 988.8 |
Nacc1 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
| K7051402 | ABM | 1.0 ug DNA | EUR 184.8 |
Nacc1 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
| K7051403 | ABM | 1.0 ug DNA | EUR 184.8 |
Nacc1 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
| K7051404 | ABM | 1.0 ug DNA | EUR 184.8 |
Nacc1 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
| K4905602 | ABM | 1.0 ug DNA | EUR 184.8 |
Nacc1 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
| K4905603 | ABM | 1.0 ug DNA | EUR 184.8 |
Nacc1 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
| K4905604 | ABM | 1.0 ug DNA | EUR 184.8 |
NACC1 3'UTR GFP Stable Cell Line |
|||
| TU065180 | ABM | 1.0 ml | EUR 1825.2 |
Nacc1 3'UTR GFP Stable Cell Line |
|||
| TU263713 | ABM | 1.0 ml | Ask for price |
Nacc1 3'UTR Luciferase Stable Cell Line |
|||
| TU113804 | ABM | 1.0 ml | Ask for price |
Nacc1 3'UTR GFP Stable Cell Line |
|||
| TU163804 | ABM | 1.0 ml | Ask for price |
NACC1 3'UTR Luciferase Stable Cell Line |
|||
| TU015180 | ABM | 1.0 ml | EUR 1825.2 |
Nacc1 3'UTR Luciferase Stable Cell Line |
|||
| TU213713 | ABM | 1.0 ml | Ask for price |
NACC1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
| K1386405 | ABM | 3 x 1.0 ug | EUR 451.2 |
NACC1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
| K1386406 | ABM | 1.0 ug DNA | EUR 200.4 |
NACC1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
| K1386407 | ABM | 1.0 ug DNA | EUR 200.4 |
NACC1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
| K1386408 | ABM | 1.0 ug DNA | EUR 200.4 |
Mouse Nucleus accumbens- associated protein 1, Nacc1 ELISA KIT |
|||
| ELI-38383m | Lifescience Market | 96 Tests | EUR 1038 |
Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
| K7051405 | ABM | 3 x 1.0 ug | EUR 451.2 |
Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
| K4905605 | ABM | 3 x 1.0 ug | EUR 451.2 |
Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
| K7051406 | ABM | 1.0 ug DNA | EUR 200.4 |
Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|||
| K7051407 | ABM | 1.0 ug DNA | EUR 200.4 |
Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|||
| K7051408 | ABM | 1.0 ug DNA | EUR 200.4 |
Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
| K4905606 | ABM | 1.0 ug DNA | EUR 200.4 |
A replicating plasmid-based vector for GFP expression in Mycoplasma hyopneumoniae.
Mycoplasma hyopneumoniae (M. hyopneumoniae) causes porcine enzootic pneumonia (PEP) that considerably impacts the pig trade worldwide. Regardless of the provision of the entire genome sequence, research on the pathogenesis of this organism have been restricted as a result of lack of a genetic manipulation system.
Subsequently, the intention of the present examine was to generate a common GFP reporter vector primarily based on a replicating plasmid. Right here, we describe the feasibility of GFP reporter expression in M. hyopneumoniae (pressure 168L) managed by the p97 gene promoter of this mycoplasma. An expression plasmid (pMD18-TOgfp) containing the p97 gene promoter, and origin of replication (oriC) of M. hyopneumoniae, tetracycline resistant marker (tetM), and GFP was constructed and used to rework competent M. hyopneumoniae cells.
We noticed inexperienced fluorescence in M. hyopneumoniae transformants beneath fluorescence microscopy, which signifies that there was expression of the GFP reporter that was pushed by the p97 gene promoter.
Moreover, an electroporation methodology for M. hyopneumoniae with an effectivity of roughly 1 x 10(-6) transformants/μg plasmid DNA was optimized and is described herein. In conclusion, our information display the susceptibility of M. hyopneumoniae to genetic manipulation whereby overseas genes are expressed. This work might encourage the event of genetic instruments to govern the genome of M. hyopneumoniae for practical genomic analyses.
Human adipose derived mesenchymal stromal cells transduced with GFP lentiviral vectors: evaluation of immunophenotype and differentiation capability in vitro.
Adipose derived mesenchymal stromal/stem cells (ASCs) are a heterogeneous inhabitants characterised by (a) their potential to stick to plastic; (b) immunophenotypic expression of sure cell floor markers, whereas missing others; and (c) the capability to distinguish into lineages of mesodermal origin together with osteocytes, chondrocytes and adipocytes. The long-term objective is to make the most of these cells for medical translation into cell-based therapies. Nonetheless, preclinical security and efficacy have to be demonstrated in animal fashions.
ASCs will also be utilized as organic autos for vector-based gene supply techniques, since they’re believed to dwelling to websites of irritation and an infection in vivo. These elements motivated the event of a labelling system for ASCs utilizing lentiviral vector-based inexperienced fluorescent protein (GFP) transduction. Human ASCs had been transduced with GFP-expressing lentiviral vectors. A titration examine decided the viral titer required to transduce the utmost variety of ASCs.
The impact of the transduced GFP lentiviral vector on ASC immunophenotypic expression of floor markers in addition to their potential to distinguish into osteocytes and adipocytes had been assessed in vitro.
Transduction effectivity in ASC cultures of roughly 80 % was noticed with an MOI of ~118. No important immunophenotypic variations had been noticed between transduced and non-transduced cells and each cell sorts efficiently differentiated into adipocytes and osteocytes in vitro. We obtained >80 % transduction of ASCs utilizing GFP lentiviral vectors.
Transduced ASCs maintained plastic adherence, demonstrated ASC immunophenotype and the flexibility to distinguish into cells of the mesodermal lineage. This GFP-ASC transduction approach provides a possible monitoring system for future pre-clinical research.
Alpha-bungarotoxin, CF568 |
|||
| 9-00006 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin, CF594 |
|||
| 9-00007 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-bungarotoxin CF594 |
|||
| 9-00007 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin, CF633 |
|||
| 9-00009 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-bungarotoxin, CF633 |
|||
| 9-00009 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin |
|||
| 00010-1 | Biotium | 1MG | EUR 201.6 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Fluorescein-Alpha-bungarotoxin |
|||
| 00011 | Biotium | 500uG | EUR 440.4 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Tetramethylrhodamine-Alpha-bungarotoxin |
|||
| 00012 | Biotium | 500uG | EUR 459.6 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Fluorescein-alpha-bungarotoxin: (10x50ug) |
|||
| 00013 | Biotium | 10ST | EUR 500.4 |
|
Description: Minimum order quantity: 1 unit of 10ST |
|||
Tetramethylrhodamine-alpha-bungarotoxin: (10x50ug) |
|||
| 00014 | Biotium | 10ST | EUR 559.2 |
|
Description: Minimum order quantity: 1 unit of 10ST |
|||
Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (500ug) |
|||
| 00015 | Biotium | 500uG | EUR 559.2 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (10x50ug) |
|||
| 00016 | Biotium | 10ST | EUR 627.6 |
|
Description: Minimum order quantity: 1 unit of 10ST |
|||
Biotin-xx-a-bungarotoxin |
|||
| 00017 | Biotium | 500uG | EUR 519.6 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-Bungarotoxin, CF555 conjugate |
|||
| 9-00018 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-Bungarotoxin, CF555 conjugate |
|||
| 9-00018 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Biotin-cAMP, diisopropylethylammonium salt: |
|||
| 00020 | Biotium | 1MG | EUR 376.8 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Biotin-cAMP, diisopropylethylammonium salt: (20x50ug) |
|||
| 00020-1 | Biotium | 20ST | EUR 501.6 |
|
Description: Minimum order quantity: 1 unit of 20ST |
|||
Biotin-cGMP, diisopropylethylammonium salt: |
|||
| 00021 | Biotium | 1MG | EUR 412.8 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Biotin-cGMP, diisopropylethylammonium salt: (20x50ug) |
|||
| 00021-1 | Biotium | 20ST | EUR 537.6 |
|
Description: Minimum order quantity: 1 unit of 20ST |
|||
Cyanine 644-cAMP: |
|||
| 00022 | Biotium | 1MG | EUR 589.2 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Cyanine 644-cAMP: (20x50ug) |
|||
| 00022-1 | Biotium | 20ST | EUR 750 |
|
Description: Minimum order quantity: 1 unit of 20ST |
|||
Fluorescein Methotrexate, triammonium salt: |
|||
| 00023 | Biotium | 1MG | EUR 337.2 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Staurosporine |
|||
| 00025 | Biotium | 100uG | EUR 166.8 |
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin, CF543 |
|||
| 00026 | Biotium | 500uG | EUR 592.8 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Rhodamine phalloidin 300u |
|||
| 00027 | Biotium | 300 | EUR 414 |
|
Description: Minimum order quantity: 1 unit of 300 |
|||
Biotin-xx-phalloidin |
|||
| 00028 | Biotium | 100U | EUR 513.6 |
|
Description: Minimum order quantity: 1 unit of 100U |
|||
Fluorescein-phalloidin |
|||
| 00030 | Biotium | 300U | EUR 414 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Rhodamine 110 phalloidin |
|||
| 00032 | Biotium | 300ST | EUR 414 |
|
Description: Minimum order quantity: 1 unit of 300ST |
|||
Sulforhodamine 101 (Texas-Red) Phalloidin |
|||
| 00033 | Biotium | 300EU | EUR 414 |
|
Description: Minimum order quantity: 1 unit of 300EU |
|||
Phalloidin, CF405M |
|||
| 00034 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF405M |
|||
| 00034-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
CF488A-cAMP |
|||
| 00036 | Biotium | 100ug | EUR 206.4 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
CF640R-cAMP |
|||
| 00037 | Biotium | 100ug | EUR 206.4 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Phalloidin, CF555 |
|||
| 00040 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF555 |
|||
| 00040-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF647 |
|||
| 00041 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF647 |
|||
| 00041-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF488A |
|||
| 00042 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF488A |
|||
| 00042-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF543 |
|||
| 00043 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF543 |
|||
| 00043-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF568 |
|||
| 00044 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF568 |
|||
| 00044-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF594 |
|||
| 00045 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF594 |
|||
| 00045-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF633 |
|||
| 00046 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF633 |
|||
| 00046-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF660R |
|||
| 00047 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF660R |
|||
| 00047-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF680R |
|||
| 00048 | Biotium | 300U | EUR 559.2 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF680R |
|||
| 00048-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF350 |
|||
| 00049 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF350 |
|||
| 00049-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF640R |
|||
| 00050 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF640R |
|||
| 00050-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF532 |
|||
| 00051 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF532 |
|||
| 00051-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF660C |
|||
| 00052 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF660C |
|||
| 00052-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF680 |
|||
| 00053 | Biotium | 300U | EUR 559.2 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF680 |
|||
| 00053-T | Biotium | 50U | EUR 176.4 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF430 |
|||
| 00054 | Biotium | 300U | EUR 538.8 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF430 |
|||
| 00054-T | Biotium | 50U | EUR 166.8 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF440 |
|||
| 00055 | Biotium | 300U | EUR 538.8 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF440 |
|||
| 00055-T | Biotium | 50U | EUR 166.8 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Cholera Toxin Subunit B, CF488A conjugate |
|||
| 00070 | Biotium | 100ug | EUR 313.2 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF568 conjugate |
|||
| 00071 | Biotium | 100ug | EUR 313.2 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF594 conjugate |
|||
| 00072 | Biotium | 100ug | EUR 313.2 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF640R conjugate |
|||
| 00073 | Biotium | 100ug | EUR 316.8 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF532 conjugate |
|||
| 00074 | Biotium | 100ug | EUR 316.8 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF543 conjugate |
|||
| 00075 | Biotium | 100ug | EUR 316.8 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF620R conjugate |
|||
| 00076 | Biotium | 100ug | EUR 316.8 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF633 conjugate |
|||
| 00077 | Biotium | 100ug | EUR 316.8 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF660R conjugate |
|||
| 00078 | Biotium | 100ug | EUR 316.8 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF680R conjugate |
|||
| 00079 | Biotium | 100ug | EUR 338.4 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Human Transferrin, CF488A conjugate |
|||
| 00081 | Biotium | 1mg | EUR 178.8 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF543 conjugate |
|||
| 00082 | Biotium | 1mg | EUR 178.8 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF568 conjugate |
|||
| 00083 | Biotium | 1mg | EUR 178.8 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF594 conjugate |
|||
| 00084 | Biotium | 1mg | EUR 178.8 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF640R conjugate |
|||
| 00085 | Biotium | 1mg | EUR 178.8 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF680R conjugate |
|||
| 00086 | Biotium | 1mg | EUR 178.8 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF750 conjugate |
|||
| 00087 | Biotium | 1mg | EUR 186 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
HIV-1 tat recombinant antigen |
|||
| 00110-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: HIV-1 tat recombinant antigen full length 15 kDa |
|||
HIV-1 tat recombinant antigen |
|||
| 00110-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: HIV-1 tat recombinant antigen full length 15 kDa |
|||
HIV-1 GAG P24 Recombinant Antigen |
|||
| 00111-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
|||
HIV-1 GAG P24 Recombinant Antigen |
|||
| 00111-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
|||